Shares of OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) Skyrocket on Announcement of Positive Results From Trial

Shares of OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) Skyrocket on Announcement of Positive Results From Trial

Biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients, OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI), announces positive survival results from the final analysis of the Phase 2 Borealis-2 trial of apatorsen. BOTHELL, Wash. and VANCOUVER, British Columbia , Oct. 25, 2016 /CNW/ — OncoGenex Pharmaceuticals, Inc. (OGXI) announced today positive survival results from the final analysis of the Phase 2 Borealis-2™ trial of […]

Read More ˃
How Will Ocera Therapeutics, Inc. (NASDAQ:OCRX)’s Share Price Respond to Announcement of News That Late-Breaker Abstract Accepted for Presentation

How Will Ocera Therapeutics, Inc. (NASDAQ:OCRX)’s Share Price Respond to Announcement of News That Late-Breaker Abstract Accepted for Presentation

Clinical-stage biopharmaceutical company, Ocera Therapeutics, Inc. (NASDAQ:OCRX), announced that it will release clinical trial data at the Liver Meeting 2016, November 11-15, 2016, in Boston. PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2016 (GLOBE NEWSWIRE) — Ocera Therapeutics, Inc. (OCRX), today announced that clinical data from STOP-ALF, a Phase 2a clinical trial to evaluate the Safety and Tolerability of Ornithine Phenylacetate (OCR-002) in patients with Acute Liver […]

Read More ˃
Legacy Reserves, LP (NASDAQ:LGCY)’s Shares on the Rise After Disclosure of ‘Not Cheap But Needed’ Second Lien Term Loan

Legacy Reserves, LP (NASDAQ:LGCY)’s Shares on the Rise After Disclosure of ‘Not Cheap But Needed’ Second Lien Term Loan

Oil and natural gas properties developer, Legacy Reserves, LP (NASDAQ:LGCY), discloses second lien term loan of $300 million. A day after Legacy Reserves LP (NASDAQ: LGCY) disclosed second lien term loan of a maximum of $300 million, Stifel termed it as “not cheap.” However, the firm thinks the company needed it badly. Following the move, analyst Brian Brungardt upgraded the stock from Sell to Hold and boosted the target price […]

Read More ˃
Shares of Tonix Pharmaceuticals Holding, Corp. (NASDAQ:TNXP) Decline After Company Prices $5.2 Million Underwritten Public Offering

Shares of Tonix Pharmaceuticals Holding, Corp. (NASDAQ:TNXP) Decline After Company Prices $5.2 Million Underwritten Public Offering

Developer of next-generation medicines for common disorders of the central nervous system, Tonix Pharmaceuticals Holding, Corp. (NASDAQ:TNXP), announces the pricing of an underwritten public offering of $5.2 million. NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (TNXP) (Tonix), today announced the pricing of an underwritten public offering of 9,500,000 units, consisting of 9,500,000 shares of common, and warrants to purchase an aggregate of 4,750,000 shares of […]

Read More ˃
Shares of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) Bump After News of $5,000,000 Public Offering of Common Stock Priced Out

Shares of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) Bump After News of $5,000,000 Public Offering of Common Stock Priced Out

Pharmaceutical company, Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR), announces pricing of $5 million public offering of common stock. LOS ANGELES, CA–(Marketwired – Oct 26, 2016) – Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR ) a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases with its lead product, RP-G28, being developed for the treatment of lactose intolerance, today announced the pricing of an underwritten public […]

Read More ˃
Shares of TheStreet, Inc. (NASDAQ:TST) Advance as News of Announcement That Fiscal 2016 Third Quarter Financial Results Will be Released on Tuesday, November 1, 2016

Shares of TheStreet, Inc. (NASDAQ:TST) Advance as News of Announcement That Fiscal 2016 Third Quarter Financial Results Will be Released on Tuesday, November 1, 2016

Leading Digital financial media company, TheStreet, Inc. (NASDAQ:TST), will announce Q3 financial results November 1st. NEW YORK, Oct. 26, 2016 /PRNewswire/ — TheStreet, Inc. (TST), a leading digital financial media company, will announce its financial results for the third quarter ended September 30, 2016, on Tuesday, November 1, 2016. The Company will host its quarterly conference call to discuss these results at 3:30 P.M. Eastern Time on Tuesday, November 1, […]

Read More ˃
Xenith Bankshares, Inc. (NASDAQ:XBKS) Announces Closing of Sale Assets of its Mortgage Banking Subsidiary

Xenith Bankshares, Inc. (NASDAQ:XBKS) Announces Closing of Sale Assets of its Mortgage Banking Subsidiary

Parent Company of Xenith Bank, Xenith Bankshares, Inc. (NASDAQ:XBKS), announces that Gateway Bank Mortgage has completed a previously announced sale of assets of GBMI to a multi-state lender. RICHMOND, Va., Oct. 17, 2016 (GLOBE NEWSWIRE) — Xenith Bankshares, Inc. (formerly known as Hampton Roads Bankshares, Inc.) (XBKS), parent company of Xenith Bank (formerly known as The Bank of Hampton Roads), announced today that Gateway Bank Mortgage, Inc. (GBMI) and its […]

Read More ˃
Shares of QuickLogic, Corp. (NASDAQ:QUIK) Advance As Company Ships 40 Millionth Display Bridge Solution

Shares of QuickLogic, Corp. (NASDAQ:QUIK) Advance As Company Ships 40 Millionth Display Bridge Solution

Developer of ultra-low power programmable sensor processing, QuickLogic, Corp. (NASDAQ:QUIK), announces that it has shipped more than 40 million units of its display bridging solutions. SUNNYVALE, CA–(Marketwired – Oct 20, 2016) – QuickLogic Corporation ( NASDAQ : QUIK ), a developer of ultra-low power programmable sensor processing, display bridge and programmable logic solutions, today announced that it has shipped more than 40 million units of its ultra-low power ArcticLink® III […]

Read More ˃
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Take a Beating After All-In Drug Fails in Late-Stage Trial

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Take a Beating After All-In Drug Fails in Late-Stage Trial

Failing to hit its goal in a late-stage trial of a drug Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) developed with intent to commercialize, shares of the pharmaceutical company took a steep dive. Shares of Rigel Pharmaceuticals Inc. plummeted Thursday, as a late-stage trial of the drug the company went all in to develop and commercialize missed its goal. The primary endpoint of a second phase 3 trial for Rigel’s fostamatinib, a treatment […]

Read More ˃
The Share Price of Jetpay, Corp. (NASDAQ:JTPY) Advance Upon Announcement of Appointment

The Share Price of Jetpay, Corp. (NASDAQ:JTPY) Advance Upon Announcement of Appointment

Leading provider of debit and credit card processing services, Jetpay, Corp. (NASDAQ:JTPY) announces that payments industry veteran Larry Stone will join the Board of Directors. BERWYN, PA–(Marketwired – October 19, 2016) – JetPay Corporation (“JetPay” or the “Company”) (JTPY), a leading provider of debit and credit card processing services, payroll and human capital management services, and prepaid card services, announced today that payments industry veteran Larry Stone has made a […]

Read More ˃